{
  "ticker": "AMGN",
  "year": 2022,
  "quarter": 2,
  "last_updated": "2025-04-15T11:21:41.933799",
  "count": 44,
  "transactions": [
    {
      "id": 1597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-23",
      "transaction_shares": "600",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "5501"
    },
    {
      "id": 1600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4886"
    },
    {
      "id": 1602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9607.8165"
    },
    {
      "id": 1608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6101"
    },
    {
      "id": 1613,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2120"
    },
    {
      "id": 1619,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13579"
    },
    {
      "id": 1622,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1930.7414"
    },
    {
      "id": 1627,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6654.1585"
    },
    {
      "id": 1628,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14461"
    },
    {
      "id": 1631,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10716"
    },
    {
      "id": 1634,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4600"
    },
    {
      "id": 1635,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18156"
    },
    {
      "id": 1603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-12",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "35333"
    },
    {
      "id": 1617,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-10",
      "transaction_shares": "13500",
      "transaction_price": "241.8114",
      "transaction_type": "S",
      "shares_after_transaction": "37333"
    },
    {
      "id": 1594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-05",
      "transaction_shares": "2017",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "619841"
    },
    {
      "id": 1595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "37",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "7344"
    },
    {
      "id": 1596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-05",
      "transaction_shares": "49",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "6006"
    },
    {
      "id": 1614,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "575",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50307"
    },
    {
      "id": 1615,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-05",
      "transaction_shares": "603",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "47784"
    },
    {
      "id": 1620,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "27340"
    },
    {
      "id": 1623,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "57661"
    },
    {
      "id": 1625,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "15",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "9404"
    },
    {
      "id": 1629,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-05",
      "transaction_shares": "574",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50833"
    },
    {
      "id": 1636,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "52",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "14869"
    },
    {
      "id": 1593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "649",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14978"
    },
    {
      "id": 1598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-02",
      "transaction_shares": "4330",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49195"
    },
    {
      "id": 1604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "433",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9437"
    },
    {
      "id": 1605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "606",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7434"
    },
    {
      "id": 1609,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-02",
      "transaction_shares": "13781",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "624550"
    },
    {
      "id": 1611,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "58958"
    },
    {
      "id": 1621,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3377",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51973"
    },
    {
      "id": 1624,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27929"
    },
    {
      "id": 1626,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1075.7414"
    },
    {
      "id": 1630,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8752.8165"
    },
    {
      "id": 1632,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51652"
    },
    {
      "id": 1633,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-02",
      "transaction_shares": "866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6109"
    },
    {
      "id": 1599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "55321"
    },
    {
      "id": 1601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "28",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "6828"
    },
    {
      "id": 1606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "48596"
    },
    {
      "id": 1607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-04-27",
      "transaction_shares": "2547",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "610769"
    },
    {
      "id": 1610,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "184",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "47755"
    },
    {
      "id": 1612,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "60",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "14329"
    },
    {
      "id": 1616,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-04-27",
      "transaction_shares": "273",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "5243"
    },
    {
      "id": 1618,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "17",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "9004"
    }
  ]
}